Nektar Therapeutics
NKTR
NKTR
176 hedge funds and large institutions have $1.9B invested in Nektar Therapeutics in 2016 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 70 increasing their positions, 61 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 179 → 176 (-3)
19% less capital invested
Capital invested by funds: $2.35B → $1.9B (-$450M)
Holders
176
Holding in Top 10
7
Calls
$3.72M
Puts
$2.9M
Top Buyers
| 1 | +$43.7M | |
| 2 | +$26.9M | |
| 3 | +$17M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$13.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.1M |
Top Sellers
| 1 | -$101M | |
| 2 | -$28.7M | |
| 3 | -$5.7M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$5.46M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$4.45M |